Our new website is live: ow.ly/m7QU50YOvst
15,000+ vetted life sciences consultants. Access in days, not months. Faster than hiring. More flexible than CROs.
#Biotech #LifeSciences
English
Clora
580 posts
Clora
@MeetClora
The best place to discover, build, and manage on-demand life science teams.
Boston, MA Katılım Eylül 2015
261 Takip Edilen189 Takipçiler
Proud to support our client @C4Therapeutics as they advance targeted #proteindegradation. They just announced an expanded long-term partnership with @Roche, highlighting strong momentum behind their platform. Read more:
ow.ly/TEsP50YKvnR
English
Biotech doesn’t have a hiring problem—it has a #resourcing strategy problem.
Only 48% of talent needs are met, while specialized roles take 100+ days to fill. Leading companies are rethinking work, bringing in #expertise on demand and prioritizing flexibility to stay on track.
English
In #biotech and #pharma, speed has been seen as a tradeoff with quality—but that’s changing. Progress now depends on fast access to the right #expertise. Leading teams use agile #talent models to tap global experts on demand, accelerating timelines without compromising rigor.
English
Which #resourcing model gives you speed, control, and quality? FTEs take 100+ days. CROs lack flexibility. See how #consultants deliver expertise without delays. Download our free reports to compare your options: ow.ly/pF9150YvZfA
English
Clora CEO @rahulc speaks with physician-scientist and #biotech founder Sheila Gujrathi, MD, about her path through biotech #leadership, building companies, and the lessons she’s learned along the way. Listen to the #podcast now.
Biotech2050 Podcast@Biotech2050Pod
This episode is sponsored by @Quartzy. Sheila Gujrathi, MD joins @rahulc on #Biotech2050 to discuss leadership, venture building, & lessons from her book The Mirror Effect on confidence, leadership & navigating power in biotech 🎧 on.soundcloud.com/RPVtOCG58wdb7k… #TheMirrorEffect #biotech
English
Biotech #IPOs may be making a comeback in 2026. After peaking with 87 U.S. #biotech IPOs in 2021, activity dropped to just 11 in 2025. Now momentum may be returning as more companies begin entering the public markets: ow.ly/fmho50YpNil
English
JPM 2026 signaled renewed optimism for #biopharma. Deals are expected to center on late-stage pipelines/assets, while R&D priorities move toward more prevalent diseases over rare/orphan indications. Read more from @BioSpace: ow.ly/Q5Cz50YlbFC
English
.@bainalerts highlights 4 trends reshaping deal strategy: vertical integration for speed and control, next-gen obesity assets, continued momentum in ADCs, & growing cross-border opportunity in Greater China. Differentiation—not scale—is driving M&A: ow.ly/UOMK50Yfmp9
English
Biopharma leaders from @Perspective_Tx, @LineageCell and Catalyst #Pharma are optimistic about 2026. Investment is returning, #science is strong, and momentum is building after a tough 2025. Read more from @FiercePharma: fiercepharma.com/pharma/fierce-…
English
Big congrats to our client, Parabilis Medicines, on closing a $305M Series F to advance their Helicon™ medicines, including a Phase 3 trial for FOG-001 in desmoid tumors. A big move in targeting tough-to-treat cancers. Read more in their press release: ow.ly/9XNy50Y0BOi
English
We’re proud to support our client as Somite becomes @CellularIntelHQ, building the first universal virtual cell-signaling model to guide, not just map, #biology. A bold step toward predictive, programmable #cellbehavior.
Micha Breakstone@MichaBreakstone
Somite is now Cellular Intelligence. More than a rebrand, this reflects what our team has been building over the last two years: the first universal virtual cell signaling model, designed to understand, predict, and ultimately control cell behavior. To further mark this step forward, we’re releasing a new white paper that shares our technical progress and maps out what is to come: cellularintelligence.com/science Deeply proud of our team for daring to turn an implausible idea into reality. Dive into what we’re creating at @CellularIntelHQ today: cellularintelligence.com
English
Will you be in the Bay Area for #JPM2026 next week?
Our CEO @rahulc will be there and would love to connect. Learn how #Clora is helping #lifesciences companies advance programs faster without the long-term cost of traditional #hiring.
Drop a comment to set up a meeting!
English
As we close out the year, we want to extend our gratitude to the life science professionals and companies we’ve had the privilege to work with.
Thank you for making 2025 a year of innovation, collaboration, and growth.
Wishing you a joyful holiday season and a Happy New Year.
English
New @Biotech2050Pod episode: Clora CEO @rahulc talks with John Lepore, CEO of @ProFoundTx, on leading in #biotech, uncovering the human proteome, and using #AI to unlock new drug targets. A look into the next frontier of #medicine. Listen using the link below.
Biotech2050 Podcast@Biotech2050Pod
The episode is sponsored by @Quartzy. 🔬 “What if we’ve only mapped a fraction of human proteins?” @rahulc interviews John Lepore, CEO of @ProFoundTx, on AI, risk-taking, & the next frontier of first-in-class medicines powered by the expanded proteome. 🎧 on.soundcloud.com/xmG2cQ8FBpkURs…
English
Biotech VC funding jumped 70.9% in Q3 2025, from $1.8B to $3.1B. Series D saw the biggest leap, up nearly 60x to $832M, a strong signal of renewed investor confidence amid ongoing challenges. Read more: ow.ly/3atQ50XzZYS
#biotech #venturecapital #biotechfunding
English
.@pfizer's $10B+ deal to acquire @MetseraInc is a major #biotech M&A move, signaling renewed #bigpharma investment. Despite ongoing industry challenges, momentum in M&A and licensing is building. Read more: ow.ly/fifz50Xt0Fo
English
🎙️ @JTananbaum, CEO of @ForesiteCapital, joins Clora CEO @rahulc to explore #biotech innovation, #AI in #drugdiscovery, and investing through market cycles. A must-listen on strategy, #science, and impact. Listen using the link below.
Biotech2050 Podcast@Biotech2050Pod
💸 Interest rates 🤖 AI 🧠 Human insight All shaping the future of biotech. 🎙️ @JTananbaum, Founder & CEO of @foresitecapital, joins @rahulc on #Biotech2050 to unpack venture cycles, AI’s rise in drug discovery, & next wave of innovation. 🎧 Listen now →on.soundcloud.com/QtQ8QCZskzFdFa…
English
Clora is heading to JPM 2026! Our CEO @rahulc will be in SF and open to meetings. Let’s talk about solving talent gaps with fractional expertise and accelerating development without traditional hiring costs. Send us a message to request a meeting. #JPM2026 #Clora #LifeSciences
English